Trajectories of Opioid Use Following Revision Total Hip Arthroplasty: A Population-Based Cohort Study
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Revision total hip arthroplasty patients show persistent opioid use, with 26% still using 2 years post-surgery. Identifying patient risk factors is crucial for personalized pain management after revision hip surgery.
Area Of Science
- Orthopedic Surgery
- Pain Management
- Public Health
Background
- Revision total hip arthroplasty (THA) patients face higher risks of persistent postoperative opioid use compared to primary THA.
- Significant safety concerns arise from associated adverse effects of prolonged opioid consumption.
- Limited understanding exists regarding temporal changes in opioid use and at-risk patient profiles following revision THA.
Purpose Of The Study
- To identify distinct opioid use trajectories within the first two years after revision THA.
- To characterize patient demographics and clinical factors associated with different opioid use patterns.
Main Methods
- A population-based cohort study of 12,314 patients undergoing first revision THA (1995-2019) using Danish Arthroplasty Registry data.
- Group-based trajectory models analyzed average daily morphine milligram equivalent (MME) from the Danish National Prescription Registry quarterly.
- Logistic regression assessed associations between clinical characteristics and trajectory group membership.
Main Results
- Opioid use declined from 74% in Q1 to 26% by Q5-Q8 post-revision THA.
- Three distinct trajectories emerged: minimal use (76%), steady use (18%), and high use (6%).
- Patients in steady and high use groups exhibited poorer health and social status compared to the minimal use group.
Conclusions
- A significant proportion (26%) of patients remain opioid users two years after revision THA, posing risks for adverse events.
- Findings highlight the necessity for tailored perioperative pain management strategies to mitigate persistent opioid use.
- Personalized approaches are essential to address the complex issue of long-term opioid dependence post-revision hip surgery.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...